Table 5.
Cost breakdown base-case results
Cost breakdown (US$) | FLOT | ECF/ECX | Incremental |
Cost of administration | 380.28 | 336.72 | 43.56 |
Cost of management | 493.33 | 1758.22 | −1264.89 |
Second lines of treatment and supportive treatment | 29 341.43 | 28 261.02 | 1080.41 |
Cost of adverse events | 748.36 | 453.18 | 295.18 |
Cost of surgery | 13 019.22 | 12 725.29 | 293.93 |
Drug costs | 2250.81 | 1777.47 | 473.34 |
ECF/ECX, epirubicin, cisplatin plus fluorouracil or capecitabine; FLOT, fluorouracil, leucovorin, oxaliplatin plus docetaxel.